These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16482517)

  • 21. Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
    Vadlamudi R; Adam L; Tseng B; Costa L; Kumar R
    Cancer Res; 1999 Jun; 59(12):2843-6. PubMed ID: 10383144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
    Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
    Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40.
    Furger C; Fiddes RJ; Quinn DI; Bova RJ; Daly RJ; Sutherland RL
    Cancer Res; 1998 May; 58(9):1773-8. PubMed ID: 9581810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
    Atlas E; Bojanowski K; Mehmi I; Lupu R
    Oncogene; 2003 May; 22(22):3441-51. PubMed ID: 12776196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of EGFR family-mediated HRG signals in human ovarian cancer.
    Campiglio M; Ali S; Knyazev PG; Ullrich A
    J Cell Biochem; 1999 Jun; 73(4):522-32. PubMed ID: 10733345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors.
    Alaoui-Jamali MA; Song DJ; Benlimame N; Yen L; Deng X; Hernandez-Perez M; Wang T
    Cancer Res; 2003 Jul; 63(13):3764-74. PubMed ID: 12839972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heregulin regulation of autocrine motility factor expression in human tumor cells.
    Talukder AH; Adam L; Raz A; Kumar R
    Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C; Klein EA; Assoian RK; Kazanietz MG
    Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heregulins implicated in cellular functions other than receptor activation.
    Breuleux M; Schoumacher F; Rehn D; Küng W; Mueller H; Eppenberger U
    Mol Cancer Res; 2006 Jan; 4(1):27-37. PubMed ID: 16446404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth factor regulation of the molecular chaperone calnexin.
    Li F; Mandal M; Barnes CJ; Vadlamudi RK; Kumar R
    Biochem Biophys Res Commun; 2001 Dec; 289(3):725-32. PubMed ID: 11726208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
    Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
    Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C
    Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells.
    Hamburger AW; Yoo JY
    Anticancer Res; 1997; 17(3C):2197-200. PubMed ID: 9216687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation.
    Bon G; Folgiero V; Bossi G; Felicioni L; Marchetti A; Sacchi A; Falcioni R
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3280-7. PubMed ID: 16740748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
    deFazio A; Chiew YE; Sini RL; Janes PW; Sutherland RL
    Int J Cancer; 2000 Aug; 87(4):487-98. PubMed ID: 10918187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors.
    Weinstein EJ; Grimm S; Leder P
    Oncogene; 1998 Oct; 17(16):2107-13. PubMed ID: 9798682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.